Risk Of Death At One Year In Patients With Non-Small Cell Lung Cancer (Nsclc) Treated With Cisplatin Regimens- An Indirect Comparison Meta-Analysis Based On Renal Eligibility Criteria
Abstract
Authors
B.K. Bellows A. Dahal N. Agarwal